Novartis Pharmaceuticals Canada Inc.
Registration:
11
of
12
(2015-04-30
to
2016-07-15)
Policies or Program
- Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products and legislative modernization
- Orphan drug policy to address treatment for rare disorders
- Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
- Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
- Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Regulation
- Food and Drug Regulations specifically with respect to approval, regulation and life-cycle management of therapeutic products
- Food and Drug Regulations with respect to Data Protection under. C.08.004
- Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations